On-Demand Webinars

  1. Reducing Macroeconomic Pressures On Clinical Trial Supply: Session 2 4/28/2023

    Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.

  2. Rethinking Effectiveness: Balancing Tradeoffs In An Era Of Disruption 11/12/2025

    In an era defined by rapid disruption and technological advancement, clinical operations leaders are under increasing pressure to enhance effectiveness while managing complex strategic trade-offs.

  3. The Digital Frontier Of Parkinson's Research: Advancing New Age Discovery 4/12/2022

    Beyond enabling data collection outside the clinic, new models are enhancing stakeholders' abilities to access more sensitive, frequent, and objective measures of Parkinson’s progression. 

  4. Patient-Centric Technologies And Tokenization In RWE Studies 5/17/2023

    Castor joins experts from United Biosource (UBC) and Datavant to discuss all things real-world evidence, patient-centric technologies, and the role of tokenization in clinical research.

  5. BYOD Is Here To Stay 5/3/2022

    In this webinar, eCOA experts will explore how to implement a BYOD strategy, relevant BYOD regulatory considerations, and where the market is going from here.

  6. Harness The Power Of eCOA In Your Next Trial

    In this webinar, explore the importance of eCOAs, how they have evolved from the standard paper diaries, and what efficiencies you can realize from them.

  7. The Top 5 Myths About eCOAs In 2025 5/15/2025

    Join leading clinical experts as they debunk the top 5 myths about eCOA in 2025, separating fact from fiction to help clinical operations, procurement, and data management teams make smarter decisions.

  8. Navigating The Journey Towards "Future-Proof" Clinical Data Assets 5/3/2021

    During this educational webinar hosted by Xtalks, data experts from ActiGraph and Koneksa Health present a roadmap to help clinical trial sponsors and their partners design and implement a “future-proof” raw data strategy to maximize the long-term value of digital biomarker data.

  9. Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials 6/24/2024

    Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.

  10. Leverage DHT Data As Patient-Centric Primary Endpoints 5/23/2023

    See how digital outcome measures of physical activity collected from ActiGraph technology as the primary endpoint in a pivotal cardiopulmonary trial were endorsed by the FDA, marking an important milestone.